Two Sigma Securities’s Eterna Therapeutics ERNA Stock Holding History

Two Sigma Securities’s Portfolio ERNA Stock Details ERNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-612	Closed	-$40.8K	–	1651
2025 Q1	$40.8K	Buy	612 +533	+675%	+$65.7K	0.01%	1019
2024 Q4	$8.74K	Sell	79 -9	-10%	-$2.44K	﹤0.01%	1447
2024 Q3	$34.5K	Buy	+88	New	+$56.3K	﹤0.01%	2418
2022 Q4	–	Sell	-2	Closed	-$4K	–	2754
2022 Q3	$4K	Buy	+2	New	+$6.89K	﹤0.01%	2487
2022 Q2	–	Sell	-2	Closed	-$32K	–	2393
2022 Q1	$32K	Buy	+2	New	+$37.9K	﹤0.01%	1924

Other funds holding ERNA

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

SCA

Sippican Capital Advisors Boston, Massachusetts $164M AUM 35.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AssetMark Inc Concord, California $49B AUM 17.78% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $3.28B AUM 23.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Two Sigma Securities's ERNA Position: Q2 2025 in Review

Two Sigma Securities sold out of Eterna Therapeutics (ERNA) in Q2 2025, closing a stake of 612 shares — an estimated $40.8K sold.

Two Sigma Securities first reported a position in ERNA in Q1 2022 and held it in 5 quarters. The position peaked at $40.8K in Q1 2025. 9 funds tracked by Wall St. Rank hold ERNA as of Q2 2025.

Two Sigma Securities reported no remaining Eterna Therapeutics position as of Q2 2025 after selling out during the quarter.
Two Sigma Securities sold 612 Eterna Therapeutics shares in Q2 2025, an estimated $40.8K.
Two Sigma Securities first reported a position in Eterna Therapeutics in Q1 2022 and held it in 5 quarters.
Two Sigma Securities's Eterna Therapeutics position peaked at $40.8K in Q1 2025.
9 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q2 2025.

Based on Two Sigma Securities's 13F filing for Q2 2025, filed 14 Aug 2025.